Vitalhub Corp. (TSE:VHI – Get Free Report) has been assigned a consensus rating of “Buy” from the five ratings firms that are covering the company, MarketBeat Ratings reports. Four investment analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. The average 1 year price target among analysts that have issued a report on the stock in the last year is C$11.92.
A number of brokerages have recently issued reports on VHI. Raymond James set a C$13.50 price objective on Vitalhub and gave the stock an “outperform” rating in a report on Thursday. Canaccord Genuity Group boosted their price target on Vitalhub from C$12.00 to C$12.50 and gave the company a “buy” rating in a research note on Thursday, January 16th. Finally, Scotiabank set a C$14.00 target price on shares of Vitalhub and gave the company an “outperform” rating in a research report on Thursday, January 30th.
Get Our Latest Stock Analysis on VHI
Vitalhub Price Performance
Vitalhub Company Profile
Vitalhub Corp., together with its subsidiaries, provides technology solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally. Its solutions include electronic healthcare record, case management, care coordination and optimization, and patient flow, engagement, and operational visibility solutions.
Further Reading
- Five stocks we like better than Vitalhub
- Basic Materials Stocks Investing
- MarketBeat Week in Review – 03/24 – 03/28
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
- There Are Different Types of Stock To Invest In
- 4 Healthcare Stocks With Massive Gains—and More to Come
Receive News & Ratings for Vitalhub Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitalhub and related companies with MarketBeat.com's FREE daily email newsletter.